The Recall Desk
HighFDA (Devices)·Z-0602-2026·Announced 2025-12-03

Respiratory test panels recalled over elevated risk of false negative results

BioFire Diagnostics is recalling 23 kits of the BioFire Respiratory Panel 2.1 because unintended movement of pouch chemistry may cause false negative results and control failures.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Scored 3 under the risk-of-harm criterion: an elevated false negative rate can leave an infection undetected, and no injuries are reported.

Plain-English summary

The BioFire Respiratory Panel 2.1, an in vitro diagnostic supplied as a 30-test kit, REF 423742, is being recalled.

Due to unintended movement of pouch chemistry, the nucleic acid test may result in an elevated risk of false negative results and a risk of control failures.

The recall covers 23 kits, totalling 690 pouches, carrying UDI 00815381020529, from lot 2649724. The product was distributed in Idaho, Oregon and Arizona. The FDA has classified the action as Class II.

A false negative on a respiratory panel can leave an infection undetected. The enforcement record reports no injuries. Laboratories holding the affected lot should stop using it and follow BioFire's instructions.

The recalled product

Product
BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)
Manufacturer
BioFire Diagnostics, LLC
Hazard
  • false-negative
  • assay-integrity
  • respiratory-testing

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • UDI: 00815381020529 /Lot # 2649724

Distribution

Distributed nationwide across the United States.